Turnera ulmifolia

Last updated

Turnera ulmifolia
Turnera ulmifolia 01.JPG
Scientific classification OOjs UI icon edit-ltr.svg
Kingdom: Plantae
Clade: Tracheophytes
Clade: Angiosperms
Clade: Eudicots
Clade: Rosids
Order: Malpighiales
Family: Passifloraceae
Genus: Turnera
Species:
T. ulmifolia
Binomial name
Turnera ulmifolia
L.

Turnera ulmifolia, the ramgoat dashalong [1] or yellow alder, is a species of plant of family Passifloraceae, native to Mexico and the West Indies. A recent study found that yellow alder potentiated the antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA). [2]

Description

Immature yellow flower Ramgoat dashalong or yellow alder.jpg
Immature yellow flower

Turnera ulmifolia grows erect, with dark toothed leaves and small, yellow-orange flowers, and is often found as a weed growing on roadsides. These yellow flowers bloom around 6:00 a.m. and wilt around 11:30 a.m. Life span for flower is around six hours. These plants can survive on minimum water and grow on walls, cement blocks, and rocks. Tawny Coster (Acraea terpsicore) butterfly larvae feed on these plants. This plant is commonly misidentified with the closely related T. diffusa in horticultural commerce, causing it to be often misrepresented as "Damiana." [3] [4] [5]

Related Research Articles

<i>Staphylococcus aureus</i> Species of Gram-positive bacterium

Staphylococcus aureus is a Gram-positive spherically shaped bacterium, a member of the Bacillota, and is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin. It is often positive for catalase and nitrate reduction and is a facultative anaerobe that can grow without the need for oxygen. Although S. aureus usually acts as a commensal of the human microbiota, it can also become an opportunistic pathogen, being a common cause of skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. Pathogenic strains often promote infections by producing virulence factors such as potent protein toxins, and the expression of a cell-surface protein that binds and inactivates antibodies. S. aureus is one of the leading pathogens for deaths associated with antimicrobial resistance and the emergence of antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), is a worldwide problem in clinical medicine. Despite much research and development, no vaccine for S. aureus has been approved.

Methicillin-resistant <i>Staphylococcus aureus</i> Bacterium responsible for difficult-to-treat infections in humans

Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from other strains of Staphylococcus aureus. MRSA is responsible for several difficult-to-treat infections in humans. It caused more than 100,000 deaths worldwide attributable to antimicrobial resistance in 2019.

<span class="mw-page-title-main">Methicillin</span> Antibiotic medication

Methicillin (USAN), also known as meticillin (INN), is a narrow-spectrum β-lactam antibiotic of the penicillin class.

Vancomycin-resistant <i>Staphylococcus aureus</i> Antibiotica resistant bacteria

Vancomycin-resistant Staphylococcus aureus (VRSA) are strains of Staphylococcus aureus that have acquired resistance to the glycopeptide antibiotic vancomycin. Bacteria can acquire resistant genes either by random mutation or through the transfer of DNA from one bacterium to another. Resistance genes interfere with the normal antibiotic function and allow a bacteria to grow in the presence of the antibiotic. Resistance in VRSA is conferred by the plasmid-mediated vanA gene and operon. Although VRSA infections are uncommon, VRSA is often resistant to other types of antibiotics and a potential threat to public health because treatment options are limited. VRSA is resistant to many of the standard drugs used to treat S. aureus infections. Furthermore, resistance can be transferred from one bacterium to another.

<i>Turnera diffusa</i> Species of shrub

Turnera diffusa, known as damiana, is a shrub native to southern Texas in the United States, Central America, Mexico, South America, and the Caribbean. It belongs to the family Passifloraceae.

<span class="mw-page-title-main">Turneraceae</span> Family of flowering plants

Turneraceae Kunth ex DC. was a family of flowering plants consisting of 120 species in 10 genera. The Cronquist system placed the Turneracids in the order Violales, but it is not currently recognized as a family by the Angiosperm Phylogeny Group in the APG III system of 2009, which includes the taxa in the Turneraceae in Passifloraceae as a subfamily (Turneroideae).

<span class="mw-page-title-main">Dicloxacillin</span> Chemical compound

Dicloxacillin is a narrow-spectrum β-lactam antibiotic of the penicillin class. It is used to treat infections caused by susceptible (non-resistant) Gram-positive bacteria. It is active against beta-lactamase-producing organisms such as Staphylococcus aureus, which would otherwise be resistant to most penicillins. Dicloxacillin is available under a variety of trade names including Diclocil (BMS).

<span class="mw-page-title-main">TAN-1057 C</span> Chemical compound

TAN-1057 C and TAN-1057 D are organic compounds found in the Flexibacter sp. PK-74 bacterium. TAN-1057 C and D are closely related structurally as diastereomers. Also related are TAN-1057 A and TAN-1057 B, isolated from the same bacteria. The four compounds have been shown to be an effective antibiotics against methicillin-resistant strains of Staphylococcus aureus which act through the inhibition of protein biosynthesis.

Lysostaphin is a Staphylococcus simulans metalloendopeptidase. It can function as a bacteriocin (antimicrobial) against Staphylococcus aureus.

<span class="mw-page-title-main">Staphylococcal infection</span> Medical condition

A staphylococcal infection or staph infection is an infection caused by members of the Staphylococcus genus of bacteria.

mecA is a gene found in bacterial cells which allows them to be resistant to antibiotics such as methicillin, penicillin and other penicillin-like antibiotics.

<span class="mw-page-title-main">Arbekacin</span> Antibiotic

Arbekacin (INN) is a semisynthetic aminoglycoside antibiotic which was derived from kanamycin. It is primarily used for the treatment of infections caused by multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA). Arbekacin was originally synthesized from dibekacin in 1973 by Hamao Umezawa and collaborators. It has been registered and marketed in Japan since 1990 under the trade name Habekacin. Arbekacin is no longer covered by patent and generic versions of the drug are also available under such trade names as Decontasin and Blubatosine.

<i>Euptoieta hegesia</i> Species of butterfly

Euptoieta hegesia, the Mexican fritillary, is a North and South American butterfly in the family Nymphalidae.

<span class="mw-page-title-main">Nargenicin</span> Chemical compound

Nargenicin is a 28 carbon macrolide with a fused tricyclic core that has in addition a unique ether bridge. The polyketide antibiotic was isolated from Nocardia argentinensis. Nargenicin is effective towards gram-positive bacteria and been shown to have strong antibacterial activity against Staphylococcus aureus, including strains that are resistant to methicillin. It has also been shown to induce cell differentiation and inhibit cell proliferation in a human myeloid leukemia cell line.

<span class="mw-page-title-main">Ceftaroline fosamil</span> Chemical compound

Ceftaroline fosamil (INN), brand name Teflaro in the US and Zinforo in Europe, is a cephalosporin antibiotic with anti-MRSA activity. Ceftaroline fosamil is a prodrug of ceftaroline. It is active against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria. It retains some activity of later-generation cephalosporins having broad-spectrum activity against Gram-negative bacteria, but its effectiveness is relatively much weaker. It is currently being investigated for community-acquired pneumonia and complicated skin and skin structure infection.

<span class="mw-page-title-main">Sophoraflavanone G</span> Chemical compound

Sophoraflavanone G is a volatile phytoncide, released into the atmosphere, soil and ground water, by members of the Sophora genus. Sophora pachycarpa, and Sophora exigua; all found to grow within the United States in a variety of soil types, within temperate conditions, no lower than 0 °F. Sophoraflavanone G is released in order to protect the plant against harmful protozoa, bacteria, and fungi. Sophoraflavanone G, also called kushenin, is a flavonoid compound.

<i>Acalypha wilkesiana</i> Species of flowering plant

Acalypha wilkesiana, common names copperleaf, Jacob’s coat and Flamengueira, is an evergreen shrub growing to 3 metres (9.8 ft) high and 2 metres across. It has a closely arranged crown, with an erect stem and many branches. Both the branches and the leaves are covered in fine hairs. The leaves, which may be flat or crinkled, are large and broad with teeth around the edge. They can be 10–20 centimetres (3.9–7.9 in) long and 15 centimetres (5.9 in) wide. The leaves are coppery green with red splashes, giving them a mottled appearance. Separate male and female flowers appear on the same plant. The male flowers are in long spikes which hang downwards while the female flowers are in short spikes. The latter do not show up easily as they are often hidden among the leaves. The flower stalks are 10–20 cm long.

Pseudoalteromonas phenolica is a marine bacterium species in the genus Pseudoalteromonas.

<i>Psidium guineense</i> Species of tree

Psidium guineense is a species of guava.

Kerry L. LaPlante is an American pharmacist, academic and researcher. She is the Dean at the University of Rhode Island College of Pharmacy. She is a Professor of Pharmacy and former department Chair of the Department of Pharmacy Practice at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, an Infectious Diseases Pharmacotherapy Specialist, and the Director of the Rhode Island Infectious Diseases Fellowship and Research Programs at the Veterans Affairs Medical Center in Providence, Rhode Island.

References

  1. USDA, NRCS (n.d.). "Turnera ulmifolia". The PLANTS Database (plants.usda.gov). Greensboro, North Carolina: National Plant Data Team. Retrieved 12 December 2015.
  2. Coutinho, Henrique DM; Costa, José GM; Lima, Edeltrudes O; Falcão-Silva, Vivyanne S; Siqueira Júnior, José P (2009). "Herbal therapy associated with antibiotic therapy: potentiation of the antibiotic activity against methicillin – resistant Staphylococcus aureus by Turnera ulmifolia L". BMC Complementary and Alternative Medicine. 9 (1): 13. doi: 10.1186/1472-6882-9-13 . ISSN   1472-6882. PMC   2685411 . PMID   19426487. Open Access logo PLoS transparent.svg
  3. Joshi, V.C.; Rao, A.S.; Wang, Y.H.; Avula, B.; Khan, I.A. (March 2009). "Taxonomic Clarification on Turnera diffusa Ward and its Demarcation from "False Damiana" using Fluorescence, Scanning Electron Microscopy, HPTLC and UPLC". Planta Medica. 75 (4). doi: 10.1055/s-2009-1216454 .
  4. "Damiana - Turnera diffusa, Turnera ulmifolia seed pictures". shroomery.org. Retrieved 7 September 2016.
  5. "Turnera diffusa var diffusa or var aphrodisiaca or what?". National Gardening Association. Retrieved 7 September 2016.